Health · 30 views
Should adults with autoimmune rheumatic conditions receive updated COVID-19 vaccines?
In an Arthritis & Rheumatology analysis of data on 60,980 U.S.
Health 
Story intelligence
Coverage Single outlet Single-outlet story
Views 30 Community interest
Brief read Under 1 min brief 49 words
AI Summary
A study of 60,980 U.S. adults with autoimmune rheumatic diseases who contracted COVID‑19 between December 2020 and August 2024 found that individuals who received booster or updated (2023–2024) COVID‑19 vaccines had a lower risk of hospitalization compared with those who only completed the initial vaccine series or remained unvaccinated.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
- Creating 'satellite maps' of thousands of proteins across tissue could transform drug therapiesContinue reading
- Is your Medicare Advantage plan ending next year? Here's what to knowContinue reading
- Ebola vaccine trial begins in DR CongoContinue reading
- Kenya announces 2nd Ebola death, a close relative of the first patientContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow